Desq Long
Sign in

Company

GeneDx Holdings Corp.

WGS · CIK 0001818331

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 1,146 shares at $0 per share.

Reporting Person Fuchs Thomas · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0002083937-26-000005 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 18,750 shares at $0 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$155,337.18

GeneDx Holdings Corp. (WGS)

Sale of 1,648 shares at $94.2580 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$14,119.94

GeneDx Holdings Corp. (WGS)

Sale of 148 shares at $95.4050 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$147,773.87

GeneDx Holdings Corp. (WGS)

Sale of 1,525 shares at $96.9009 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$406,936.07

GeneDx Holdings Corp. (WGS)

Sale of 4,141 shares at $98.2700 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$300,845.80

GeneDx Holdings Corp. (WGS)

Sale of 3,039 shares at $98.9950 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 7,197 shares at $0 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$55,235.19

GeneDx Holdings Corp. (WGS)

Sale of 586 shares at $94.2580 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$4,961.06

GeneDx Holdings Corp. (WGS)

Sale of 52 shares at $95.4050 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$52,423.39

GeneDx Holdings Corp. (WGS)

Sale of 541 shares at $96.9009 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$144,456.90

GeneDx Holdings Corp. (WGS)

Sale of 1,470 shares at $98.2700 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$106,815.61

GeneDx Holdings Corp. (WGS)

Sale of 1,079 shares at $98.9950 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001944119-26-000037 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 6,547 shares at $0 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001689575-26-000030 · filed 2026-09-11 · View filing →

SEC FORM 4
$310,932.12

GeneDx Holdings Corp. (WGS)

Sale of 3,692 shares at $84.2178 per share.

Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001689575-26-000030 · filed 2026-09-11 · View filing →

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 2,462 shares at $0 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001944119-26-000035 · filed 2026-09-11 · View filing →

SEC FORM 4
$108,220.00

GeneDx Holdings Corp. (WGS)

Sale of 1,285 shares at $84.2179 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001944119-26-000035 · filed 2026-09-11 · View filing →

SEC FORM 4
$0.00

GeneDx Holdings Corp. (WGS)

Acquisition (code M) of 717 shares at $0 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001944119-26-000033 · filed 2026-09-03 · View filing →

SEC FORM 4
$31,188.11

GeneDx Holdings Corp. (WGS)

Sale of 372 shares at $83.8390 per share.

Reporting Person Feeley Kevin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001944119-26-000033 · filed 2026-09-03 · View filing →